Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- Subjects who are administered alectinib at physician's discretion and fall into the approved indication in Korea.
You may not be if
Hypersensitivity to alectinib or any ingredient of alectinib;
Pregnant or lactating women;
Pediatric subjects (age \</=18 years);
Due to the presence of lactose, subjects with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take alectinib.
Clareo Health | Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea
